11/18/2021
5 Innovations That Are Changing the Delivery of Care
Experts at Cleveland Clinic have invested in research and technology designed to improve outcomes and the patient experience. From diagnosis and biopsy to surgical approaches and longer-term management—learn more about how the team is leading the way in prostate cancer.
11/02/2021
First U.S. Patient Enrolled in Cardionomic's CPNS Pilot Study
Cardionomic, Inc., a Minneapolis medical device company, is pleased to announce initial U.S. enrollment in their global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study (NCT04814134). The study is evaluating the safety and performance of the CPNS System in patients suffering from acute decompensated heart failure (ADHF), defined as new or worsening symptoms of heart failure. The first U.S. patient was enrolled and implanted at The Ohio State University Wexner Medical Center in Columbus, OH by Principal Investigator, Dr. Sitaramesh Emani, assisted by Dr. Rami Kahwash
10/26/2021
Cleveland Clinic Launches First-of-its-Kind Preventative Breast Cancer Vaccine Study
Cleveland Clinic has begun clinical testing of a novel vaccine designed ultimately to prevent triple-negative breast cancer (TNBC) by priming high-risk women to mount an immune response against a “retired” lactation protein expressed only in cancer cells
10/19/2021
Cleveland Clinic Surgical Team Performs First Right-Sided Robotic Liver Resection
Traditional liver surgery is performed through one open incision incision below the ribs or along the midline and takes a significant amount of recovery. Over the past 10 years, minimally invasive liver resection has emerged as a viable alternative. This robotic-assisted right-sided hepatectomy was the first one performed at Cleveland Clinic.
10/11/2021
Opening of Cleveland Clinic BioRepository Expands Infrastructure for Pursuit of Personalized Medicine
Cleveland Clinic and Brooks Automation have opened the Cleveland Clinic BioRepository to increase the storage capacity for biological samples at Cleveland Clinic while enhancing researchers’ study of human tissue samples to more rapidly translate laboratory discoveries into new treatments for patients.
09/14/2021
Cleveland Diagnostics Presents New Data Supporting the Clinical Validation and Clinical Utility of ISoPSA
Cleveland Diagnostics, Inc., a commercial stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, announced today that Eric Klein, MD, Chairman of the Glickman Urological & Kidney Institute at Cleveland Clinic, delivered two presentations at the annual meeting of the American Urological Association regarding the company’s prostate cancer test, IsoPSA
09/07/2021
Bionic Arm's Neurorobotic Sensory-Motor Fusion Restores Natural Behaviors
In a new study published in Science Robotics, a Cleveland Clinic-led research team reports that it has engineered a first-of-its-kind neurorobotic prosthetic arm for patients with upper-limb amputations that allows wearers to think, behave and function more like a person without an amputation.
07/28/2021
New VR Platform Fuses Physical and Virtual Worlds in Parkinson's Disease and Beyond
Recently scientists at Cleveland Clinic have developed a solution to the locomotion problem and have created a truly immersive VR experience. They are initiating research to use their platform to understand and better treat freezing of gait in patients with Parkinson’s disease (PD). Future research plans include use of the platform for early identification of PD and other neurodegenerative disorders in older adults.
06/20/2021
Q&A: Cleveland Clinic Innovations’ new head has his eyes trained on the future
In a wide-ranging interview, Dr. Geoff Vince, the new executive director of Cleveland Clinic Innovations, discussed his plans for how the commercialization arm will operate, the technologies he thinks will drive interest and whether the pandemic has changed approaches to innovation.
06/10/2021
Cleveland Clinic, IBM, Aetna teaming up to launch blockchain health firm
Cleveland Clinic, IBM, Aetna and Anthem have partnered to form a blockchain health firm, called Avaneer Health. The Chicago-based healthcare company will aim to use blockchain capabilities to make healthcare more efficient and reduce administrative costs, according to a June 9 news release.